CEO/Founding Director/Professor at Terasaki Institute for Biomedical Innovation, Los Angeles, CA (2020-)
UCLA Professor (2017-2020)
Harvard Professor, Cambridge, MA (2005-2017)
Harvard-MIT HST Professor, Cambridge, MA (2005-2017)
MIT Ph.D. in Bioengineering, Cambridge (2001-2005)
Amazon Scientist, Seattle (2019-2020)
Co-Founder and Board member of Obsidio and BioRAE.
Scientific Advisory Board member of Cellink
Full time dad (2017-)
ACS Nano Assocaite Editor
Lived in Tehran, Toronto, Boston and Los Angeles
World traveler (pre-COVID)
He is a leader in applying bioengineering solutions to personalized medicine. His large and interdisciplinary group is interested in developing ‘personalized’ solutions that utilize micro- and nanoscale technologies to enable a range of therapies for organ failure, cardiovascular disease, and cancer.
He has edited multiple books/journal special issues and is an author on >650 peer-reviewed journal articles, editorials and review papers, >70 book chapters/edited books, and >20 patents or patent applications. His work has been published in leading journals and routinely highlighted in international media. He has been cited >80000 times and has an H-index of 146. Annually since 2014, he has been selected by Thomson Reuters as one of the World’s Most Influential Minds as a Highly Cited Researcher.
Dr. Khademhosseini’s interdisciplinary research has been recognized by over 60 major national and international awards. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Royal Society of Chemistry (RSC), Biomaterials Science and Engineering (FBSE), Materials Research Society (MRS), NANOSMAT Society, and American Association for the Advancement of Science (AAAS). He is also the recipient of the Mustafa Prize as well as a member of the International Academy of Medical and Biological Engineering, Royal Society of Canada, and Canadian Academy of Engineering.
LinkedIn: Ali Khademhosseini
Invited by: Xiaoyu Miao
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
June 26, 2024 | 8,766 | +1 | +0.1% |
May 23, 2024 | 8,765 | -9 | -0.2% |
April 21, 2024 | 8,774 | -8 | -0.1% |
March 14, 2024 | 8,782 | -6 | -0.1% |
February 21, 2024 | 8,788 | -7 | -0.1% |
January 18, 2024 | 8,795 | -1 | -0.1% |
January 01, 2024 | 8,796 | -2 | -0.1% |
December 17, 2023 | 8,798 | +2 | +0.1% |
December 01, 2023 | 8,796 | -3 | -0.1% |
November 17, 2023 | 8,799 | -3 | -0.1% |